Medplus IPO Date, Price, Review, Details, Analysis, Valuation, GMP Today

Medplus IPO Date | Medplus Health IPO Price Today | Medplus IPO Valuation | Medplus IPO Analysis |

According to the Technopak Report, MedPlus Health Services Limited is India’s second-largest pharmacy operator in terms of income from operations for the financial year 2021 and the number of outlets as of March 31, 2021. The Medplus IPO will take place on December 13, 2021.

About MedPlus Health Services Limited Company

Gangadi Madhukar Reddy, their Managing Director, and Chief Executive Officer founded their company in 2006 intending to make a reliable pharmacy retail brand that offers genuine medicines and provides greater value to customers by minimizing inefficiencies in the supply chain through innovation. According to the Technopak Report, they are India’s second-largest pharmacy retailer in terms of revenue from operations for the financial year 2021 and store count as of March 31, 2021. Medplus IPO sells a variety of products, including pharmaceutical and wellness products like medicines, vitamins, medical gadgets, and test kits, as well as fast-moving consumer goods like toiletries, infant care products, soaps, and detergents, and hand sanitizers.

The company has a robust pharmacy retail network of 2,165 outlets throughout Tamil Nadu, Andhra Pradesh, Telangana, Karnataka, Odisha, West Bengal, and Maharashtra as of June 30, 2021. Based on revenue from operations in Chennai, Bangalore, Hyderabad, and Kolkata in the financial year 2021, its share of the organized pharmacy retail market was 30 percent, 29 percent, 30 percent, and 22 percent, respectively. It employs a cluster-based retail network growth strategy, in which it first establishes a high shop concentration in a densely populated residential area inside a target market. Bengaluru, Chennai, Hyderabad, Vijaywada, Kolkata, Pune, Bhubaneshwar, Mumbai, and Nagpur are among the company’s warehouses. Gangadi Madhukar reddy, lone furrow investments private limited, and agilemed investments private limited are the company’s promoters. Axis Capital Limited, Credit Suisse Securities (India) Private Limited, Edelweiss Financial Services Limited, and Nomura Financial Advisory and Securities (India) Private Limited are the issue’s lead managers, and KFin Technologies Private Limited is the issue’s Registrar.

Medplus IPO

Medplus Health IPO Competitive Advantages

Some of the major Competitive advantages are as follows:

  • A powerful brand name and a compelling customer value proposition.
  • In India, it is the second-largest pharmacy store.
  • Customers are the first to benefit from an Omni-channel platform provided by a pharmacy.
  • In Tamil Nadu, Andhra Pradesh, Telangana, Karnataka, Odisha, West Bengal, and Maharashtra, there are about 2000 pharmacies.
  • A highly qualified, experienced, and competent management team.

Other Related IPO Search

Shriram Properties IPO

MapmyIndia IPO

Star Health IPO

Anand Rathi IPO

RateGain IPO

Metro Brands IPO

Company Risks

Some of the major companies’ risks are as follows:

  • Price and commercial terms changes in prescription medicines may have a bad effect on their business.
  • The use and sharing of individually sensitive information, particularly personal health information, is governed by privacy and security standards.
  • COVID-19’s future consequence on their business is uncertain and cannot be predicted.
  • If we do not efficiently manage inventories and estimate demand, their financial success may be compromised
  • Their business, subsidiaries, promoters, and directors are all embroiled in legal proceedings. Any bad decision made in any of these processes could have a detrimental influence on their business.
  • Cyber-attacks and information technology system failures may put them at risk.

Objectives of Medplus IPO

  • To achieve the company’s joint goals.
  • Prepayment or repayment of all or a portion of the company’s ongoing borrowings on a consolidated basis.

Medplus IPO Date & Price Band Details 

IPO Opening DateDec 13, 2021
IPO Closing DateDec 15, 2021
Face Value₹2 per equity share
Issue TypeBook Built Issue IPO
Market Lot18 Shares
IPO Price₹780 to ₹796 per equity share
Min Order Quantity18 Shares
Issue Size[.] Eq Shares of ₹2(aggregating up to ₹1,398.30 Cr)
Offer for Sale[.] Eq Shares of ₹2(aggregating up to ₹798.30 Cr)
Fresh Issue[.] Eq Shares of ₹2(aggregating up to ₹600.00 Cr)
Employee Discount78
Listing AtBSE, NSE
Retail Shares Offered35% of the net offer
QIB Shares Offered50% of the net offer
NII (HNI) Shares Offered15% of the net offer

Tentative Timetable for Medplus IPO 

The Tentative Timetable for Medplus IPO is given in the table below

IPO Opening Date 13 December 2021
IPO Closing Date15 December 2021
Basis of Allotment20 December 2021
Refunds21 December 2021
Credit to Demat Account22 December 2021
IPO Listing Date23 December 2021

Medplus IPO Market Lot

Minimum Lot Size:Minimum 18 Shares for 1 lot
Maximum Lot Size:Maximum 234 Shares for 13 lot
Minimum Amount:₹14,328 for 1 lot
Maximum Amount:₹186,264for 13 lot

Basis of Allotment

TypePercent of OfferBasis of Allotment
Qualified Institutional Buyer50 percentRoughly equivalent
Retail35 percentThe minimum level of 1 lot, based on availability, for every shareholder.
Non-Institutional Investor15 percentRoughly equivalent

Medplus IPO Financial Report

The Medplus IPO Financial Report is given in the table below:

31 – March -202131 – March -2020March – 2019
Total Assets15,656.58 Million13,486.96 Million9,587.11 Million
*Total Revenue30,908.14 Million28,878.87 Million22,849.40 Million
Total Expense29,957.16 Million28,585.28 Million22,621.89 Million
Profit After Tax631.11 Million17.94 Million119.22 Million

Earnings per Equity Share 

Basic30.64 Million1.05 Million5.76 Million
Diluted29.38 Million1.01 Million5.52 Million

Company Promoters

The Medplus IPO is as follows:

S. No.Company Promoters Name

Basic and Diluted Earnings per Share

Financial PeriodDiluted EPS (in INR)Basic EPS (in INR)Weight
Financial Year 20215.886.133
Financial Year 20200.200.212
Financial Year 20191.101.151
Weighted Average3.193.33

Promoters Holding for Medplus IPO

Pre Issue Share Holding43.16%
Post Issue Share Holding40.43%


DateGMP (in Rs)Subject to SaudaKostak (in Rs)
07 December 2021220
December 2021
December 2021
December 2021
December 2021
December 2021
December 2021
December 2021
December 2021
December 2021
December 2021
December 2021

MedPlus IPO Subscription Status

DateDayQIBNIIRetailEmployeesTotal Subscription
13 December 20211
14 December 20212
15 December 20213

Medplus IPO Reviews or Ratings

Axis CapitalNeutral

MedPlus IPO Brokerage Views

Axis Securities: Not Updated
Yes Securities:Not Updated
ICICI Securities:Not Updated
Trade swift:Not Updated
Choice Brokering:Not Updated
IIFL Securities:Not Updated
Anand Rathi:Not Updated

List of Related Parties i.e., Key Managerial Personnel

S. No.Managerial Personnel NameDesignation
Gangadi Madhukar ReddyManaging Director and Chief Executive Officer
Atul GuptaNon-Executive Director
Anish Kumar SarafNon-Executive Director
Madhavan GanesanNon-Executive Independent Director
Murali SivaramanNon-Executive Independent Director
Hiroo MirchandaniNon-Executive Independent Director

Lead Managers of Medplus IPO

Some of the Lead Managers of Medplus IPO is as follows:

S. No.Managers Name
Credit Suisse Securities (India) Private Limited
Nomura Financial Advisory and Securities (India) Private Limited
Axis Capital Limited
Edelweiss Financial Services Limited

Medplus IPO Registrar

Address:KFin Technologies Private LimitedSelenium, Tower B, Plot No- 31 and 32, Financial District, Nanakramguda, Serilingampally, Hyderabad, Rangareedi 500 032, Telangana, India
Contact Number:04067162222,04079611000
E-mail id:[email protected]
Official Website:

Company Address: